Migraine: the evolution of anti-CGRP monoclonal antibodies
Alpha-synuclein dosage methods in the various forms of Parkinson's
it
Prof. Alfredo Berardelli
Alzheimer, which clinical and organizational perspectives for the new monoclonals
it
Prof. Alessandro Padovani
Possible applications of AI in management of neurological diseases
it
Prof. Stefano F. Cappa
Neurological complications from Covid-19: incidence and sequelae
it
Prof. Carlo Ferrarese
MS: many therapies available today. The challenge is to customize treatments
it
Prof. Massimo Filippi
Sleep quality and neurodegenerative diseases
it
Prof. Giuseppe Plazzi
Neuromuscular diseases: a rapidly evolving therapeutic landscape
it
Prof. Antonio Toscano
ALS management, valuable support from AI and Machine Learning
it
Prof. Vincenzo Silani
Identifying patients with preclinical forms of Alzheimer's
it
Prof. Camillo Marra
Migraine: the evolution of anti-CGRP monoclonal antibodies
it
Prof. Antonio Russo